Sildenafil Citrate 100 - Pharmaceutical Grade

Sildenafil citrate, discovered in 1989, acts by inhibiting phosphodiesterase type 5, allowing for sustained cGMP activity in smooth muscle cells. Initially targeting cardiovascular conditions like angina, its unexpected benefits in treating erectile dysfunction redirected its development. Approved and launched in 1998 as Viagra, it was backed by extensive clinical trials. The drug quickly became the benchmark for ED therapy, praised for its consistent efficacy and wide patient tolerability.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Sildenafil Citrate 100 by Pharmaceutical Grade, consult with your doctor or healthcare professional.